FCPM III SERVICES B.V.

Q4 2024 13F Holdings

  • Location
    naarden, P7
  • Num holdings

    8

  • Value ($000)

    $592,382

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0002013410
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
N62509109
$272.35M
46 %

10,597,181

DYN
DYN

DYNE THERAPEUTICS INC

COM
26818M108
$128.70M
22 %

5,462,846

ENGN
ENGN

ENGENE HOLDINGS INC

COM
29286M105
$64.06M
11 %

9,632,561

BCYC
BCYC

BICYCLE THERAPEUTICS PLC

SPONSORED ADS
088786108
$48.33M
8 %

3,452,330

REPL
REPL

REPLIMUNE GROUP INC

COM
76029N106
$48.08M
8 %

3,970,668

ATXS
ATXS

ASTRIA THERAPEUTICS INC

COM
04635X102
$25.68M
4 %

2,872,537

ACHL
ACHL

ACHILLES THERAPEUTICS PLC

SPONSORED ADS
00449L102
$2.75M
1 %

2,390,050

ENGNW
ENGNW

ENGENE HOLDINGS INC

W EXP 10/31/2028
29286M113
$2.43M
0 %

2,878,148

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 8 of 8